TrialAIDS research and human retroviruses2010

Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.

Lisa L Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.